Tom Miller, Ph.D., is a scientist and entrepreneur with a focus on the nexus of AI, chemistry and biology. In 2020, he co-founded and became CEO of Iambic Therapeutics, a clinical-stage biotechnology company that is disrupting the therapeutics landscape with a unique, AI-driven, drug-discovery platform. Prior to Iambic, Tom served over 10 years as a professor at the California Institute of Technology (Caltech), receiving tenure, publishing over 140 peer-reviewed articles and patents, and receiving numerous awards for research and entrepreneurial excellence. Tom earned a B.S. in Chemistry and Mathematics from Texas A&M University and a Ph.D. in Theoretical Chemistry from the University of Oxford. He is an independent director at Veracyte (Nasdaq: VCYT), a leading genomic diagnostics company.